Scope and impact of early and late preterm infants admitted to the PICU with respiratory illness
- PMID: 20338574
- PMCID: PMC2892737
- DOI: 10.1016/j.jpeds.2010.02.006
Scope and impact of early and late preterm infants admitted to the PICU with respiratory illness
Abstract
Objective: To determine the clinical course and outcomes of children born early preterm (EPT, <32 weeks), late preterm (LPT, 32 to 35 weeks), and full term (FT, >or=36 weeks) who were subsequently admitted to the pediatric intensive care unit (PICU) with respiratory illness.
Study design: Retrospective chart review of patients <2 years old admitted to a tertiary PICU with respiratory illness.
Results: Two hundred seventy-one patients met inclusion criteria: 17.3% were EPT, 12.2% were LPT, and 70.5% were FT. Lower respiratory tract infection was the most common diagnosis (55%) for all groups. Median PICU length of stay was longer for EPT (6.3 days) and LPT infants (7.1 days) compared with FT infants (3.7 days; P < .03 for both comparisons). EPT and LPT infants had longer hospital stays (median, 11.7 and 13.8 days, respectively) compared with FT infants (median, 7.1 days; P < .03 and P = .004, respectively). Median hospital charges were also greater for EPT ($85 151) and LPT ($83 576) groups compared with FT group ($55 122; P < .01 and P < .02, respectively).
Conclusions: EPT and LPT infants comprise a considerable proportion of PICU admissions for respiratory illness and have greater resource utilization than FT infants.
Copyright (c) 2010 Mosby, Inc. All rights reserved.
Figures


Similar articles
-
Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants.J Perinatol. 2016 Nov;36(11):990-996. doi: 10.1038/jp.2016.113. Epub 2016 Aug 4. J Perinatol. 2016. PMID: 27490190 Free PMC article.
-
Clinical and Virological Characteristics of Early and Moderate Preterm Infants Readmitted With Viral Respiratory Infections.Pediatr Infect Dis J. 2015 Jul;34(7):693-9. doi: 10.1097/INF.0000000000000718. Pediatr Infect Dis J. 2015. PMID: 25923427
-
Serum palivizumab level is associated with decreased severity of respiratory syncytial virus disease in high-risk infants.Hum Vaccin Immunother. 2014;10(10):2789-94. doi: 10.4161/hv.29635. Hum Vaccin Immunother. 2014. PMID: 25483663 Free PMC article. Clinical Trial.
-
Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data.Lancet. 2024 Mar 30;403(10433):1241-1253. doi: 10.1016/S0140-6736(24)00138-7. Epub 2024 Feb 14. Lancet. 2024. PMID: 38367641
-
Predisposition of infants with chronic lung disease to respiratory syncytial virus-induced respiratory failure: a vascular hypothesis.Pediatr Infect Dis J. 2004 Jan;23(1 Suppl):S33-40. doi: 10.1097/01.inf.0000108191.13799.09. Pediatr Infect Dis J. 2004. PMID: 14730268 Review.
Cited by
-
Recent advances in antenatal factors predisposing to bronchopulmonary dysplasia.Semin Perinatol. 2018 Nov;42(7):413-424. doi: 10.1053/j.semperi.2018.09.002. Epub 2018 Oct 5. Semin Perinatol. 2018. PMID: 30389227 Free PMC article. Review.
-
Physiologic Pulmonary Phenotyping of Infants Born Preterm and Post-Discharge Respiratory Morbidity.J Pediatr. 2025 Apr;279:114475. doi: 10.1016/j.jpeds.2025.114475. Epub 2025 Jan 22. J Pediatr. 2025. PMID: 39855623 Free PMC article.
-
Intensive care unit readmission during childhood after preterm birth with respiratory failure.J Pediatr. 2014 Apr;164(4):749-755.e3. doi: 10.1016/j.jpeds.2013.11.062. Epub 2013 Dec 31. J Pediatr. 2014. PMID: 24388320 Free PMC article. Clinical Trial.
-
The economic impact of prematurity and bronchopulmonary dysplasia.Eur J Pediatr. 2017 Dec;176(12):1587-1593. doi: 10.1007/s00431-017-3009-6. Epub 2017 Sep 9. Eur J Pediatr. 2017. PMID: 28889192
-
Multidisciplinary guidelines for the care of late preterm infants.J Perinatol. 2013 Jul;33 Suppl 2(Suppl 2):S5-22. doi: 10.1038/jp.2013.53. J Perinatol. 2013. PMID: 23803627 Free PMC article. No abstract available.
References
-
- Gregoire MC, Lefebvre F, Glorieux J. Health and developmental outcomes at 18 months in very preterm infants with bronchopulmonary dysplasia. Pediatrics. 1998 May;101:856–60. - PubMed
-
- Furman L, Baley J, Borawski-Clark E, Aucott S, Hack M. Hospitalization as a measure of morbidity among very low birth weight infants with chronic lung disease. J Pediatr. 1996 Apr;128:447–52. - PubMed
-
- Gross SJ, Iannuzzi DM, Kveselis DA, Anbar RD. Effect of preterm birth on pulmonary function at school age: a prospective controlled study. J Pediatr. 1998 Aug;133:188–92. - PubMed
-
- Smith VC, Zupancic JA, McCormick MC, Croen LA, Greene J, Escobar GJ, et al. Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia. J Pediatr. 2004 Jun;144:799–803. - PubMed
-
- Prais D, Schonfeld T, Amir J. Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use. Pediatrics. 2003 Sep;112:548–52. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous